Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CENTENE CORPORATION

(CNC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Centene Corporation Announces Organizational Enhancements, Establishes the Office of President

07/13/2021 | 04:46pm EDT

Centene Corporation announced an organizational enhancement approved by the Board of Directors. In an effort to further recognize the size and scale of the company, broaden executives' capabilities, and support Centene's continued growth and innovation, the company has created the Office of the President (OOP). The OOP will be comprised of Michael Neidorff, Brent Layton and Sarah London. The OOP will be effective immediately. Michael Neidorff will continue to serve as Chairman, President and Chief Executive Officer. Under the OOP, Mr. Layton and Ms. London will continue to report to Michael Neidorff. Brent Layton, previously appointed to President of U.S. Health plans, Products, and International and Executive Vice President will retain responsibility over Health Plans, Products and International. Mr. Layton has worked with Centene for over 20 years, first as a consultant for five years and then joining Centene as an employee in 2006. Sarah London, previously appointed President, Health Care Enterprises and Executive Vice President of Advanced Technology, will continue in these roles.


© S&P Capital IQ 2021
All news about CENTENE CORPORATION
09/15WALL STREET STOCK EXCHANGE : Yes, the global economic recovery is slowing
09/15ANALYST RECOMMENDATIONS : Chevron, Centene, Darktrace, Flutter, Malibu Boats...
09/14CENTENE : Mizuho Securities Adjusts Centene PT to $75 From $67, Maintains Neutra..
MT
09/14CENTENE : Morgan Stanley Adjusts Centene's Price Target to $79 from $88, Keeps O..
MT
09/14CENTENE : Credit Suisse Adjusts Price Target for Centene to $70 From $73.50, Mai..
MT
09/14REMINDER : Centene Corporation's 2021 Third Quarter Financial Results Conference..
PR
09/08CENTENE : Bernstein Adjusts Centene's Price Target to $92 from $102, Keeps Outpe..
MT
09/08CENTENE : Mizuho Securities Adjusts Centene PT to $67 From $75, Maintains Neutra..
MT
09/07RITE AID : Subsidiary Elixir Names Lance Neill Chief Operating Officer
MT
09/07CENTENE : BRENT LAYTON NAMED PRESIDENT AND CHIEF OPERATING OFFICER (Form 8-K)
PU
More news
Analyst Recommendations on CENTENE CORPORATION
More recommendations
Financials (USD)
Sales 2021 125 B - -
Net income 2021 1 191 M - -
Net Debt 2021 9 280 M - -
P/E ratio 2021 32,2x
Yield 2021 -
Capitalization 37 688 M 37 688 M -
EV / Sales 2021 0,38x
EV / Sales 2022 0,37x
Nbr of Employees 71 300
Free-Float 96,0%
Chart CENTENE CORPORATION
Duration : Period :
Centene Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CENTENE CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 64,64 $
Average target price 84,58 $
Spread / Average Target 30,8%
EPS Revisions
Managers and Directors
Michael F. Neidorff Chairman & Chief Executive Officer
Brent Davis Layton President & Chief Operating Officer
Andrew Lynn Asher Chief Financial Officer & Executive Vice President
Mary V. Mason Chief Medial Officer & Senior Vice President
Ken Yamaguchi Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
CENTENE CORPORATION7.68%37 688
UNITEDHEALTH GROUP18.87%396 176
ANTHEM, INC.16.77%92 533
CIGNA CORPORATION-1.28%69 933
HUMANA INC.-2.71%52 403
MOLINA HEALTHCARE, INC.30.78%16 243